Monte Rosa Therapeutics

Price & Volume

Stats

52W Range	$3.51-$25.77
Market Cap	$1.3B
Shares Short	13M

Financials

Revenue (12 Mos)	$123.6M
Revenue Growth (YoY)	-95.4%
Gross Profit (12 Mos)	-$10M
Diluted EPS	-$0.46

News

Yahoo Finance • 24 days ago

Monte Rosa J J Supply Deal Refocuses MRT 2359 Prostate Cancer Story

Yahoo Finance • 29 days ago

Monte Rosa Therapeutics Announces Clinical Supply Agreement to Support Phase 2 Trial Evaluating MRT-2359 in Combination with Apalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Yahoo Finance • 5 months ago

Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases

Yahoo Finance • 5 months ago

Monte Rosa Therapeutics Announces Third Quarter 2025 Financial Results and Business Updates

About

CEO	Dr. Markus Warmuth M.D.
Address	321 Harrison Avenue, Boston, MA, United States, 02118
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	150